The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC).
Adi Diab
No relevant relationships to disclose
Heather L. McArthur
Research Funding - Bristol-Myers Squibb
Stephen Barnett Solomon
No relevant relationships to disclose
Virgilio Sacchini
No relevant relationships to disclose
Christopher Comstock
No relevant relationships to disclose
Majid Maybody
No relevant relationships to disclose
Jeremy C. Durack
No relevant relationships to disclose
Brian Blum
No relevant relationships to disclose
Jianda Yuan
Research Funding - Bristol-Myers Squibb
Sujata Patil
No relevant relationships to disclose
Deirdre A. Neville
No relevant relationships to disclose
Elizabeth Anne Comen
No relevant relationships to disclose
Elizabeth Ann Morris
No relevant relationships to disclose
Alan Kotin
No relevant relationships to disclose
Edi Brogi
No relevant relationships to disclose
Monica Morrow
No relevant relationships to disclose
James Patrick Allison
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Honoraria - Bristol-Myers Squibb
Clifford A. Hudis
No relevant relationships to disclose
Larry Norton
No relevant relationships to disclose
Jedd D. Wolchok
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb